Why Rare Disease Therapeutics Need Early Market Access Planning
About The Episode When developing and bringing a therapeutic for a rare disease to market, sponsors should think with the end in mind and plan for payer requirements early in protocol design. The eco...
21 Joulu 202231min
Effective Concentration for a Longer Period with Long Acting Injectables
In this podcast, you will hear a presentation from Dr Liping Zhou, AstraZeneca, from the 2022 PODD Conference regarding formulation techniques and developability considerations for LAI peptide deliver...
20 Joulu 202222min
Moderna on Innovating Clinical Trial Partnerships to Expand Access
In this session recorded at DPHARM 2022, Moderna discusses its recent partnership with CVS Health to bring its clinical trial closer to patients and expand patient access into more communities. Review...
20 Joulu 202215min
Regeneron and Novartis on Innovating to Accommodate Growing Pipelines
In this session recorded at DPHARM 2022, Bari Kowal, SVP & Head, Development Operations and Portfolio Management, Regeneron, moderates a panel discussion on: Examining how modernizations like the impl...
19 Joulu 202229min
Development of the Lipid Nanoparticles
In this podcast, you will hear a keynote presentation from Dr Peter Cullis, UBC, from the 2021 PODD Conference regarding the path of discovery and innovation that led to the lipid nanoparticle deliver...
19 Joulu 202236min
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
Learn more about the IO360° Summit at www.io360summit.com
14 Joulu 202220min
Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies
Evaluating single cell omics to understand the heterogeneity in immune and tumor cellsMulti-omic biomarkers for patient selection in solid tumor IO: is there a path to more personalized therapy?In an ...
12 Joulu 202243min
Chair’s Opening Presentation with Barbara Lueckel Summary
In this podcast, you will hear a presentation from Dr Barbara Lueckel, Roche Pharma Partnering, from the 2021 PODD Conference summarizing trends, approvals and pipelines within the drug delivery space...
12 Joulu 202221min
